Citius Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.67
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.04
|
-0.05
|
-0.01
|
-25.00%
|
|
2022-06-30
|
-0.05
|
-0.06
|
-0.01
|
-20.00%
|
|
2022-03-31
|
-0.07
|
-0.05
|
0.02
|
28.57%
|
|
2021-12-31
|
-0.06
|
-0.06
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.04
|
-0.02
|
0.02
|
50.00%
|
|
2021-06-30
|
-0.06
|
-0.06
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.07
|
-0.04
|
0.03
|
42.86%
|
|
2020-12-31
|
0.16
|
-0.15
|
-0.31
|
-193.75%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.00
|
|
2022-09-30
|
-0.22
|
|
2021-09-30
|
-0.27
|
|
2020-09-30
|
-0.46
|
|
2019-09-30
|
-0.78
|
|
2018-09-30
|
-1.17
|
|
2017-09-30
|
-1.91
|
|
2016-09-30
|
-2.16
|
|
2015-09-30
|
-1.36
|